Companies/US/IRD

OPUS GENETICS, INC.

Last · —$4.045-0.008718 (-0.22%)live · yahoo · 1h ago
Vol 602.1K ≈ 2.44M
Market cap$386.03M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session

Issuer

Legal nameOPUS GENETICS, INC.
HQUnited States (US)
ListingUS IRD
ISINUS67577R1023
LEI529900C85NBMQFSETD92
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001228627
CIK0001228627
Websiteopusgtx.com
Employees28
AddressOcuphire Pharma, Inc. 8 Davis Drive 27709, Durham
Loading chart…

Upcoming earnings

1 event
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.15
Est. revenue
2.1M
View upcoming earnings →

Earnings transcripts

1 recent

Press & signals

2 recent
  • GlobeNewswire

    Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • GlobeNewswire

    Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update

Documents

FormReporting forFiledFlags
4
2026-09-302026-10-020
8-KCurrent Report (8-K)
—2026-09-110
4
2026-09-092026-09-110
8-KCurrent Report (8-K)
—2026-09-090
4
2026-09-082026-09-080
Showing 5 of 19 filings